🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer

Recruitingn/aAges 50 Years - anyAllChanghai Hospital
NCT07117045 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, with early diagnosis crucial for improving survival. Due to the absence of effective screening methods, most patients are diagnosed at advanced stages. The population undergoing low-dose computed tomography (LDCT) screening significantly overlaps with those at high risk for PDAC; however, traditional imaging methods have limited sensitivity for detecting pancreatic lesions. This study utilizes the Pancreatic Cancer Detection with Artificial Intelligence (PANDA) system to enhance LDCT for pancreatic cancer screening in a prospective, multicenter, observational cohort. PANDA will analyze LDCT images, followed by a multidisciplinary team (MDT) reassessment of abnormal interpretations. Based on MDT evaluation, individuals will be recalled for further examination, placed under a personalized follow-up plan, or monitored for at leas

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Age 50 years and above. 2. Voluntary signing of informed consent. 3. Completion of LDCT examination. Exclusion Criteria: 1. Previous history of pancreatic cancer. 2. Abdominal inflammation or diagnosis of acute pancreatitis within 6 months. 3. Poor image quality due to ascites, pancreatic trauma, thoracic/abdominal surgery, radiotherapy or chemotherapy. 4. Research subjects unable to complete follow-up due to physical or other reasons.
💊

What it tests

  • Diagnostic Evaluation for Positive AI Findings
📍

Where

5 sites
Meinian Onehealth Healthcare Holdings Co., Ltd
Shanghai, China
Ruici Medical Examination Institution
Shanghai, China
Changhai Hospital
Shanghai, China
Jiaxing University Affiliated Second Hospital
Jiaxing, China
Ningbo University Affiliated People's Hospital
Ningbo, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy